Overview

POC Blood Glucose Monitoring Devices Market Overview:

Blood glucose levels are checked to see how much insulin is needed and when it is needed. Blood sugar levels that fluctuate a lot might be harmful to your health in several ways. Blood sugar levels that are excessively high (hyperglycemia) or too low (hypoglycemia) can be harmful and even fatal if they are not treated quickly. Keeping monitoring of people's blood glucose levels is thus one of the most effective ways to learn about diabetes and how different foods, drugs, and activities affect their diabetes. The formulation of a management strategy for this illness can be aided by keeping track of blood glucose levels. Furthermore, people use a portable glucometer known as blood glucose monitoring to monitor their blood sugar levels. The metre measures the amount of sugar in a small sample of blood taken from the patient's fingertip and placed on a disposable test strip. A needle delicately pricks the skin to draw blood. Blood sugar metres indicate whether your blood sugar is now high or low. Even if someone uses a continuous glucose monitor (CGM), they must calibrate the CGM device on a daily basis with a blood sugar metre. Near-patient testing, commonly known as point-of-care testing (POCT), is a method of monitoring diabetes patients. In the outpatient context, point-of-care glucose monitoring devices are a significant tool for managing diabetic patients. Furthermore, the use of a point-of-care glucose testing gadget and electronic healthcare records allows for immediate communication of test results with healthcare practitioners. High demand will fuel the growth of the Point of Care Glucose Monitoring Devices market. This gadget aids in speedy decision-making abilities, reducing turnaround time and improving patient care. When POCT is used in glucose testing, life-threatening conditions like hypoglycemia seizures and diabetic ketoacidosis can be reversed. In addition to its benefits, it has the drawback of occasionally producing erroneous results, which can lead to healthcare management errors.

FutureWise Market Research has instantiated a report that provides an intricate analysis of POC Blood Glucose Monitoring Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the POC Blood Glucose Monitoring Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the POC Blood Glucose Monitoring Devices Market:
• Abbott
• ARKRAY
• Ascensia Diabetes Care
• Danaher
• F. Hoffmann-La Roche
• Johnson & Johnson
(Note: The list of the major players will be updated with the latest market scenario and trends)

POC Blood Glucose Monitoring Devices Market Segmentation:
By Type
• Consumable
• Instruments
By Application
• Hospital& Clinics
• Clinical Diagnostic Laboratories
• Homecare Settings
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the POC Blood Glucose Monitoring Devices Market By Type, By Application and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1. Objectives of the Study
  1.2. Market Definition
  1.3. Market Scope
       1.3.1. Years Considered for the Study
       1.3.2. Market Covered
  1.4. Currency
  1.5. Limitations
  1.6. Stakeholders

2. Research Methodology
   2.1. Research Data
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation
   2.3. Market Breakdown and Data Triangulation
   2.4. Assumptions for the Study  

3. Executive Summary
  3.1. Market Outlook
  3.2. Segment Outlook
  3.3. Competitive Insights

4. POC Blood Glucose Monitoring Devices Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Type Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of POC Blood Glucose Monitoring Devices Market Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. POC Blood Glucose Monitoring Devices Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Type Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Type Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. POC Blood Glucose Monitoring Devices Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)
  7.1. Consumable
  7.2. Instruments

8. POC Blood Glucose Monitoring Devices Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)  
  8.1. Hospital& Clinics
  8.2. Clinical Diagnostic Laboratories
  8.3. Homecare Settings

9. North America POC Blood Glucose Monitoring Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
  9.1. Introduction
  9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
       9.2.1. U.S.A
       9.2.2. Canada
       9.2.3. Mexico
  9.3. Market Size (USD Million) Forecast for North America 2022-2028

10. Latin America POC Blood Glucose Monitoring Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   10.1. Introduction
   10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         10.2.1. Brazil
         10.2.2. Venezuela
         10.2.3. Argentina
         10.2.4. Rest of Latin America
   10.3. Market Size (USD Million) Forecast for Latin America 2022-2028

11. Europe POC Blood Glucose Monitoring Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   11.1. Introduction
   11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         11.2.1. Germany
         11.2.2. U.K        
         11.2.3. France
         11.2.4. Italy
         11.2.5. Spain
         11.2.6. Russia
         11.2.7. Poland
         11.2.8. Rest of Europe
   11.3. Market Size (USD Million) Forecast for Europe 2022-2028

12. Asia Pacific POC Blood Glucose Monitoring Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   12.1. Introduction
   12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         12.2.1. Japan
         12.2.2. China
         12.2.3. India
         12.2.4. Australia and New Zealand
         12.2.5. ASEAN
         12.2.6. Rest of Asia Pacific
   12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         13.2.1. GCC
         13.2.2. Israel
         13.2.3. South Africa
         13.2.4. Rest of MEA
   13.3. Market Size (USD Million) Forecast for MEA 2022-2028

14. Market Share Analysis and Competitive Landscape  
   14.1. Global Landscape - Key Players, Revenue and Presence
   14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   14.3. Global Emerging Companies
   14.4. North America - Market Share Analysis and Key Regional Players
   14.5. Europe - Market Share Analysis and Key Regional Players
   14.6. Asia Pacific - Market Share Analysis and Key Regional Players
   14.7. Global Key Player - Growth Matrix

15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   15.1. Abbott
         15.1.1. Company Overview
         15.1.2. Product Portfolio
         15.1.3. SWOT Analysis
         15.1.4. Financial Overview
         15.1.5. Strategic Overview
   15.2. ARKRAY
         15.2.1. Company Overview
         15.2.2. Product Portfolio
         15.2.3. SWOT Analysis
         15.2.4. Financial Overview
         15.2.5. Strategic Overview                        
   15.3. Ascensia Diabetes Care
         15.3.1. Company Overview
         15.3.2. Product Portfolio
         15.3.3. SWOT Analysis
         15.3.4. Financial Overview
         15.3.5. Strategic Overview
   15.4. Danaher
         15.4.1. Company Overview
         15.4.2. Product Portfolio
         15.4.3. SWOT Analysis
         15.4.4. Financial Overview
         15.4.5. Strategic Overview
   15.5. F. Hoffmann-La Roche
         15.5.1. Company Overview
         15.5.2. Product Portfolio
         15.5.3. SWOT Analysis
         15.5.4. Financial Overview
         15.5.5. Strategic Overview          
   15.6. Johnson & Johnson
         15.6.1. Company Overview
         15.6.2. Product Portfolio
         15.6.3. SWOT Analysis
         15.6.4. Financial Overview
         15.6.5. Strategic Overview      
 
16. Pre and Post COVID-19 Impact
   16.1. Positive influence on the healthcare industry
   16.2. The financial disruption of the manufacturing sector
   16.3. Impact of COVID-19 on emerging companies
   16.4. Significant mandates in the healthcare regulations initiated by administrations
   16.5. The overall economic slowdown of the developing and developed nations

17. FutureWise SME Key Takeaway Points for Client

Tables

Figures